Back to Blog
Editorial lifestyle photograph illustrating semaglutide before-and-after weight loss timeline
AnalysisGuidesJUNE 4, 2026· 12 min read
By Iacob Pastina, Independent Editor & Researcher
Reviewed & updated June 4, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

Semaglutide Before and After: Weight Loss Results by Month

Clinical trials show 15–17% body weight loss with semaglutide over 68 weeks. Here's what to expect month by month, backed by data from the STEP trials.

Independently researched. Every statistic links to a primary source (NEJM, JAMA, FDA, CMS, or the provider's official disclosures). Affiliate status never changes a provider's score; featured picks are affiliate partners, disclosed. Last verified June 4, 2026.

Summarize this article with

In this article
  1. 01Semaglutide Weight Loss Timeline: Month by Month
  2. 02STEP Trial Results: The Clinical Evidence
  3. 03What Affects Your Results?
  4. 04Semaglutide vs Tirzepatide: Which Produces Better Results?
  5. 05What Happens When You Stop Semaglutide?
  6. 06How to Maximize Your Results
  7. 07Getting Started: Cheapest Semaglutide Options
  8. 08Frequently Asked Questions
  9. 09Sources

People taking semaglutide 2.4mg (Wegovy) lost an average of 15–17% of their body weight over 68 weeks in the landmark STEP clinical trials, that's roughly 35 lbs for someone starting at 230 lbs. Weight loss follows a predictable curve: modest in months 1–2 as the dose ramps up, accelerating through months 3–6, and plateauing around months 12–16. One-third of participants lost 20% or more of their body weight. Here's a detailed timeline of what to expect, backed by published trial data. See providers ranked by lowest semaglutide price, or take our match quiz to find the best fit.

Semaglutide Weight Loss Timeline: Month by Month

Semaglutide is prescribed as a once-weekly injection with a gradual dose increase over 16–20 weeks. Weight loss tracks closely with the dose escalation, here's what the clinical data shows:

TimeframeDoseAverage Weight LostWhat to Expect
Month 1–20.25mg → 0.5mg2–4% (~5–9 lbs)Appetite suppression begins. Some nausea as your body adjusts. Most people notice reduced food cravings within the first 2 weeks.
Month 3–41.0mg5–8% (~12–18 lbs)Weight loss accelerates. Nausea typically subsides. Clothing fits differently. Most noticeable visual changes begin.
Month 5–61.7mg → 2.4mg8–12% (~18–28 lbs)Reaching maintenance dose. Significant visible changes. Energy levels often improve as excess weight decreases.
Month 7–92.4mg (maintenance)12–15% (~28–35 lbs)Approaching peak weight loss. Body composition changes become dramatic. Blood markers (A1C, triglycerides) often normalize.
Month 10–122.4mg (maintenance)14–16% (~32–37 lbs)Weight loss slows as you approach your new set point. Focus shifts to maintenance and habit consolidation.
Month 12–16+2.4mg (maintenance)15–17% (~35–39 lbs)Plateau phase. Weight stabilizes. The STEP-1 trial showed weight remains stable through week 68 with continued use.
ImportantThese are averages from clinical trials with 2.4mg semaglutide (Wegovy). Individual results vary significantly, some participants lost over 20% while others lost less than 5%. Compounded semaglutide may produce different results since dosing, formulation, and purity vary by pharmacy.

Comparing your options?

See every verified GLP-1 program ranked side by side on cost, safety, and care quality.

Compare all 52GLP-1 providers →

STEP Trial Results: The Clinical Evidence

The STEP (Semaglutide Treatment Effect in People with Obesity) trials are the largest and most rigorous studies of semaglutide for weight loss. Here's what each trial found:

TrialParticipantsDurationAverage Weight LossKey Finding
STEP 11,961 adults with obesity68 weeks14.9% (vs 2.4% placebo)One-third lost 20%+ body weight
STEP 21,210 adults with T2 diabetes + obesity68 weeks9.6% (vs 3.4% placebo)Effective even with type 2 diabetes, though less than non-diabetic patients
STEP 3611 adults with obesity + behavioral therapy68 weeks16.0% (vs 5.7% placebo)Adding behavioral intervention increased results to 16%
STEP 4902 adults (withdrawal study)68 weeks17.4% lost during treatmentParticipants regained 2/3 of weight within 1 year of stopping
STEP 5304 adults with obesity2 years15.2% (vs 2.6% placebo)Weight loss maintained over 2 years of continued treatment

The most important finding: the STEP 4 withdrawal study showed that patients regained approximately two-thirds of their lost weight within one year of stopping semaglutide. This confirms that semaglutide works as ongoing treatment, not a short-term fix.

The GLP-1 Letter · Free

Every Tuesday. One email. The cheapest verified GLP-1 programs of the week.

Price drops, FDA alerts, new programs ranked, and compounded shortages, delivered Tuesday morning. No filler. Unsubscribe anytime.

No affiliate spam. No retargeting pixels. Unsubscribe in one click.

What Affects Your Results?

Clinical trial averages don't tell the whole story. Several factors influence how much weight you'll lose on semaglutide:

  • Starting weight, People with higher starting BMI tend to lose a larger absolute amount of weight, though percentage loss is similar across weight ranges.
  • Dose reached, The 2.4mg maintenance dose produced the best results in trials. Some patients can't tolerate the full dose and stay at 1.0mg or 1.7mg, which produces less weight loss (approximately 10–12%).
  • Diet and exercise, The STEP 3 trial added intensive behavioral therapy (diet counseling + exercise) and achieved 16% weight loss vs 14.9% in STEP 1 with medication alone.
  • Type 2 diabetes, Patients with T2 diabetes lost less weight (9.6% in STEP 2 vs 14.9% in STEP 1), likely due to insulin resistance and diabetes medications that promote weight gain.
  • Genetics and metabolism, About 10–15% of trial participants were classified as 'non-responders' who lost less than 5% body weight despite full dosing. There's no reliable way to predict this in advance.
  • Consistency, Missing doses reduces efficacy. The weekly injection schedule must be maintained consistently for optimal results.

Semaglutide vs Tirzepatide: Which Produces Better Results?

If you're comparing options, tirzepatide (Zepbound/Mounjaro) produces significantly more weight loss than semaglutide in head-to-head trials:

MetricSemaglutide (Wegovy)Tirzepatide (Zepbound)
Average weight loss15–17% (STEP trials, 68 weeks)20–22.5% (SURMOUNT trials, 72 weeks)
Head-to-head (SURMOUNT-5)13.7%20.2% (p<0.001)
Patients losing 20%+~33%~57%
MechanismGLP-1 receptor agonistDual GIP + GLP-1 receptor agonist
Monthly cost (compounded)$99–$199/mo$149–$300/mo

Tirzepatide costs $50–$150/month more but produces roughly 50% more weight loss. Read our full semaglutide vs tirzepatide comparison or see tirzepatide cost breakdown for pricing details.

Editor's Top Pick

TrimRx

$149/mo · 7.8/10 · Compounded

Budget-friendly compounded GLP-1 provider with straightforward pricing and a focus on accessibility.

What Happens When You Stop Semaglutide?

The STEP 4 trial directly studied what happens after discontinuation, and the results are sobering. After achieving 17.4% weight loss over 20 weeks, participants who switched to placebo regained approximately two-thirds of their lost weight over the following year. Those who continued semaglutide maintained their weight loss.

This doesn't mean semaglutide is a failure, it means obesity is a chronic condition that requires ongoing treatment, similar to blood pressure medication. The American Medical Association and the Obesity Medicine Association both classify obesity as a chronic disease requiring long-term management.

Planning for Long-Term UseIf you're starting semaglutide, plan for ongoing treatment. Use our savings calculator to estimate your total cost over 6, 12, and 24 months. Affordable long-term options include Yucca Health ($146/mo), Strut Health ($149/mo oral), and Sprout Health ($199 first month, then $249/mo all-inclusive with dedicated care coordinator). See all providers ranked by lowest monthly price.
Verify Your Provider Match

Not sure which GLP-1 program is right for you?

Take the 60-second quiz, we'll match you against 52 verified providers on your goals, budget, and medication preference, then surface your top 3.

Take the 60-sec Quiz

How to Maximize Your Results

  • Follow the dose escalation schedule, Don't rush to the maintenance dose. The gradual increase (0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg over 16–20 weeks) reduces side effects and improves long-term adherence.
  • Prioritize protein intake, GLP-1 medications can cause muscle loss alongside fat loss. Aim for 0.7–1.0g protein per pound of body weight daily to preserve lean mass. The STEP 3 trial included dietary guidance and saw better outcomes.
  • Add resistance training, Weight-bearing exercise helps preserve muscle during rapid weight loss. Even 2–3 sessions per week makes a measurable difference in body composition.
  • Stay hydrated, Semaglutide slows gastric emptying, which can cause constipation. Drinking 80+ oz of water daily helps manage this common side effect.
  • Track your progress monthly, not weekly, Weight fluctuates daily due to water retention, food timing, and hormonal cycles. Monthly measurements give a more accurate picture of your trajectory.
  • Communicate with your provider, If nausea persists beyond the first month or weight loss stalls, your provider can adjust timing, suggest anti-nausea strategies, or modify your dose. Our dosing timeline tool shows what a typical titration schedule looks like.

Getting Started: Cheapest Semaglutide Options

If you're ready to start semaglutide, here are the most affordable ways to access it in 2026:

  • Low-cost compounded tirzepatide (note: bulk compounded semaglutide was banned by FDA in 2025): Enhance MD starts at $99 first month ($280/mo after), Shed at $199/mo, and Sprout Health at $199 first month ($249/mo after). See all providers ranked by price.
  • Mid-range with more support: Sprout Health ($199 first month, then $249/mo) includes a dedicated care coordinator and published outcomes data, the most clinically supported active partner in our table.
  • Brand-name with insurance: If your insurance covers Wegovy, apply for the Novo Nordisk savings card for $25/month copays.
  • Prefer pills over injections? Oral semaglutide weight loss is possible via the Wegovy pill (16.6% loss, $25/mo with commercial insurance) or Foundayo ($149/mo self-pay, no fasting). See our oral GLP-1 weight loss pills guide for a full comparison.
  • Medicare: As of July 2026, Part D covers Wegovy at $50/month through the GLP-1 Bridge Demonstration. See our Medicare GLP-1 coverage guide.
  • Not sure which provider? Take our 7-question match quiz to find the best provider for your budget, insurance status, and preferences.

Frequently Asked Questions

How much weight will I lose on semaglutide in 3 months? Based on the STEP trials, most patients lose 5–8% of their body weight in the first 3 months (roughly 12–18 lbs for a 230-lb person). You'll still be ramping up to the maintenance dose during this period, so weight loss accelerates after month 3.

Do semaglutide results last? As long as you continue treatment, yes. The STEP 5 trial showed sustained weight loss over 2 full years of treatment. However, stopping semaglutide typically leads to weight regain, the STEP 4 withdrawal study showed approximately two-thirds of lost weight returned within one year of stopping.

Is semaglutide worth it? For most patients with a BMI of 30+ (or 27+ with comorbidities), semaglutide produces significant, clinically meaningful weight loss with manageable side effects. The STEP trials showed improvements in blood pressure, blood sugar, triglycerides, and waist circumference alongside weight loss. The main consideration is cost and the commitment to long-term use.

What are the most common side effects? Nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%) were the most common in STEP 1. Most side effects occur during dose escalation and resolve within 4–8 weeks. Read our GLP-1 side effects management guide for detailed strategies.

Sources

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.

Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.

Find your GLP-1 program, our Top Pick is TrimRx

Our featured pick, drawn from our independent ranking of 52 verified providers, at $149/mo all-in.

Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment

Compare every GLP-1 program in one place

See all 52 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.

Medicare & GLP-1

Medicare GLP-1 Coverage Guide

Saw Medicare mentioned in "Semaglutide Before and After: Weight Loss Results by Month"? Here's exactly what's covered, who qualifies, and how the $50/mo Bridge copay works from July 1, 2026.

Read the Medicare Coverage Guide →
Independent Clinical Perspective

What the doctors say

Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.

Patients on both medications experienced substantial weight loss, and we observed no difference in the risk of gastrointestinal adverse events. In addition to effectiveness, factors like medication availability and insurance coverage will likely play a role in deciding which medication to initiate.
Nicholas L. Stucky, MD, PhD, physician; co-author, real-world tirzepatide vs semaglutide study
Truveta Research / Providence Portland Medical Center
On real-world findings that practical factors matter beyond raw efficacy.
For more than a million people at high risk of heart attack and stroke, this treatment on the NHS could be life-changing – offering a powerful new way to protect their hearts and improve their health.
Helen Williams, Consultant pharmacist; National Clinical Director for Cardiovascular Disease Prevention
NHS England
NHS England announcing semaglutide (Wegovy) availability to cut heart attack and stroke risk.
NHS England · Apr 2026
So-called 'weight loss drugs' like semaglutide have proven benefits beyond reducing the number on the scales – they are now considered important medicines for preventing deadly heart attacks and strokes. Today's guidance will no doubt help save lives as cardiovascular disease is still one of the country's biggest killers.
Sonya Babu-Narayan, Consultant cardiologist; Clinical Director, British Heart Foundation
British Heart Foundation
British Heart Foundation reacting to NICE recommending semaglutide for cardiovascular event prevention.

Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Embody

7.3/10
$149/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.